Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 1
2004 3
2014 1
2015 2
2016 2
2017 4
2018 2
2019 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Triple-negative breast cancer in the elderly.
Shagisultanova E, Mayordomo J, Elias AD. Shagisultanova E, et al. Breast J. 2017 Nov;23(6):627-629. doi: 10.1111/tbj.12814. Breast J. 2017. PMID: 29112794 No abstract available.
Issues in interpreting the in vivo activity of Aurora-A.
Shagisultanova E, Dunbrack RL Jr, Golemis EA. Shagisultanova E, et al. Expert Opin Ther Targets. 2015 Feb;19(2):187-200. doi: 10.1517/14728222.2014.981154. Epub 2014 Nov 11. Expert Opin Ther Targets. 2015. PMID: 25384454 Free PMC article. Review.
Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.
Kagihara JA, Shagisultanova E, Afghahi A, Diamond JR. Kagihara JA, et al. Among authors: shagisultanova e. Curr Breast Cancer Rep. 2021 Sep;13(3):216-226. doi: 10.1007/s12609-021-00416-0. Epub 2021 May 4. Curr Breast Cancer Rep. 2021. PMID: 34457184
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2.
Shagisultanova E, Crump LS, Borakove M, Hall JK, Rasti AR, Harrison BA, Kabos P, Lyons TR, Borges VF. Shagisultanova E, et al. Mol Cancer Ther. 2022 Jan;21(1):48-57. doi: 10.1158/1535-7163.MCT-21-0098. Epub 2021 Nov 2. Mol Cancer Ther. 2022. PMID: 34728571 Free PMC article.
Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study.
West AH, Knollman H, Dugan J, Hedeker D, Handorf EA, Nielsen SM, Bealin LC, Goldblatt LG, Willems H, Daly MB, Afghahi A, Olopade OI, Hulick PJ, Shagisultanova E, Huo D, Obeid E, Churpek JE. West AH, et al. Among authors: shagisultanova e. Cancer Med. 2019 Sep;8(12):5609-5618. doi: 10.1002/cam4.2471. Epub 2019 Aug 12. Cancer Med. 2019. PMID: 31407530 Free PMC article.
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
Korobeynikov V, Borakove M, Feng Y, Wuest WM, Koval AB, Nikonova AS, Serebriiskii I, Chernoff J, Borges VF, Golemis EA, Shagisultanova E. Korobeynikov V, et al. Among authors: shagisultanova e. Breast Cancer Res Treat. 2019 Sep;177(2):369-382. doi: 10.1007/s10549-019-05329-2. Epub 2019 Jun 28. Breast Cancer Res Treat. 2019. PMID: 31254157 Free PMC article.
22 results